OmniReliant Holdings, Inc. Acquires Topical Pharmaceutical Patent

OmniReliant Holdings, Inc., ("OmniReliant" or the "Company") (OTCBB:ORHI), licensee of Kathy Hilton Fragrance, announced today that it has formally acquired the rights to a unique patented topical pharmaceutical product capable of delivering salicylic acid in a non-stick clear solid composition to treat acne.

OmniReliant will use the patented product to compliment the company's patent pending warming foam acne treatment product.

Lead scientists William Bess and Leonard Mackles, who conceived the product, have agreed to sell the patent and collaborate with OmniReliant Holdings, Inc. to bring this breakthrough formula to the highly competitive acne treatment market.

Paul W. Morrison, CEO of OmniReliant Holdings, Inc., said, "Management considers it is important to acquire patented technology in order to contend in the aggressive acne treatment market.

We believe this patent enhances our portfolio by adding the knowledge of respected academics and allows OmniReliant to bring unique products to market that can make a difference.

We will continue to work with pharmaceutical industry veterans William Bess and Len Mackles, as their expertise and extensive research produces acne treatment products that allow us to fulfill the needs of a vast consumer base who desire an over-the-counter product."

William Bess has over 38 years of development experience on all facets of personal care, pharmaceutical and household product development. He is the inventor/co-inventor of six U.S. patents and several current U.S. patent applications. Bess' work experience includes 20 years as a development scientist at Bristol Meyers Company (NYSE:BMY) and is in his fifteenth year as Product Development Director at Warner Lambert Consumer Health Care and Pfizer Consumer Health Care .

Leonard Mackles has over 55 years of experience in the development of consumer, pharmaceutical, food, beverage and household products. He has worked for several international consumer products companies, including Schenley Research Institute and Bristol Myers Company, and has invented/co-invented nearly 200 U.S. and International patents with several current patent applications under review. Mackles is the president and owner of Link Laboratories Inc., a technology development firm founded in 1984 that specializes in developing patentable consumer product technologies for licensing or sale to marketing firms.

OmniReliant also announced today that Paul W. Morrison was promoted to CEO and appointed to the board of directors. Mr. Morrison, who is also the President of OmniReliant Holdings, Inc. will be replacing Chris Phillips, who will still maintain his seat on the board. "I look forward to guiding the Company during these exciting times in the Company's early stages, by building distribution and bringing new products to market, leveraging licensed names and intellectual property. During my tenure with OmniReliant, we have already become a registered vendor with HSN, QVC and Macy's," said Mr. Morrison.

OmniReliant revealed today that Kathy Hilton is launching her new fragrance, My Secret by Kathy Hilton, on My Secret by Kathy Hilton will also be available on In conjunction with this exciting news, Ms. Hilton has decided to further entice her customers with an exciting promotion for Mother's Day.

Presented by My Secret by Kathy Hilton, the "My Secret" Mother's Day contest goes live January 24th on, with the grand prize of one mother/daughter set winning a memorable and priceless holiday - round trip tickets to Los Angeles, an overnight stay at the Beverly Hills Hilton and a private lunch on Saturday, May 10th, with Kathy, Paris and Nicky, to talk beauty, family and much more.

Source :

0 التعليقات:

  ©Template by Dicas Blogger.